HDFC Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1568 Cr | ₹1208 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.14 | 2.14 |
Manager | Dhruv Muchhal | Meeta Shetty |
ISIN Code | INF179KC1HL7 | INF277K016A9 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 4.26% | 2.49% |
6 Month | 1.91% | -1.68% |
1 Year | 26.66% | 13.65% |
3 Year | - | 24.87% |
5 Year | - | 21.5% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 6.23% | 4.16% |
1 Year | 13.72% | 3.59% |
3 Year | - | 23.77% |
5 Year | - | 19.49% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 34.78% | 9.47% |
3 Year | - | 18.04% |
5 Year | - | 14.89% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | - | 16.538% |
Sharp | - | 0.681% |
Beta | - | 0.969% |
Alpha | - | 0.018% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhruv Muchhal | Meeta Shetty |
Total AUM | ₹520687 Cr | ₹17847 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.17 | 5.06 |
Small Cap | 34.62 | 27.82 |
Large Cap | 35.28 | 35.26 |
Mid Cap | 25.93 | 31.87 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 2.47 | 4.34 |
Basic Materials | 2.04 | 2.22 |
Healthcare | 95.49 | 93.44 |
Top Comparisons
Nippon India Equity Savings Fund- Growth Plan- Bonus Option
3Y Returns7.98%
Invesco India Equity Savings Fund - Regular Plan - Growth
3Y Returns12.41%
Kotak Emerging Equity Scheme - Growth
3Y Returns26.47%
Nippon India Growth Fund-Growth Plan-Growth Option
3Y Returns30.16%
BANDHAN Core Equity Fund - Regular Plan - Growth
3Y Returns28.79%
Tata Large & Mid Cap Fund- Regular Plan - Growth Option
3Y Returns20.9%
HDFC Multi-Asset Active FOF - Growth
3Y Returns17.93%
Motilal Oswal Asset Allocation FOF- A- Regular Growth
3Y Returns18.08%